Stock Track | Harrow Health Soars 6.93% in Pre-Market on Insider Buying by President and CFO
Stock Track
May 15
Harrow Health Inc's stock soared 6.93% in pre-market trading on Friday, following news of significant insider buying by the company's leadership.
The pre-market surge came after a regulatory filing revealed that Harrow President and Chief Financial Officer Andrew R. Boll purchased 3,500 common shares in open-market transactions at $29.90 per share, totaling approximately $104,650. Following this purchase, Boll's directly held stake in the company increased to 814,679 shares.
Such insider buying activity is often viewed by investors as a strong vote of confidence from company executives, signaling their belief in the company's future prospects and potentially indicating that the stock is undervalued at current levels.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.